Concepts (153)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Leukemia, Myeloid, Acute | 2 | 2026 | 192 | 0.350 |
Why?
|
| Chromosome Breakage | 4 | 2011 | 6 | 0.340 |
Why?
|
| Mutation | 6 | 2026 | 2629 | 0.300 |
Why?
|
| Congenital Abnormalities | 2 | 2008 | 26 | 0.290 |
Why?
|
| Human Development | 1 | 2008 | 9 | 0.280 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 2021 | 70 | 0.260 |
Why?
|
| Hybrid Cells | 1 | 2005 | 19 | 0.240 |
Why?
|
| Genome, Human | 1 | 2008 | 240 | 0.240 |
Why?
|
| Centromere | 1 | 2005 | 41 | 0.240 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2026 | 63 | 0.230 |
Why?
|
| GTP Phosphohydrolases | 1 | 2026 | 64 | 0.230 |
Why?
|
| Chromosomes, Human | 1 | 2005 | 52 | 0.230 |
Why?
|
| Dioxygenases | 1 | 2024 | 25 | 0.210 |
Why?
|
| Chromosome Aberrations | 4 | 2013 | 67 | 0.190 |
Why?
|
| Antibodies, Bispecific | 1 | 2021 | 29 | 0.170 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2021 | 85 | 0.160 |
Why?
|
| Abnormalities, Multiple | 3 | 2013 | 54 | 0.160 |
Why?
|
| DNA-Binding Proteins | 2 | 2024 | 1196 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 3 | 2 | 2007 | 12 | 0.130 |
Why?
|
| Craniofacial Abnormalities | 2 | 2007 | 22 | 0.130 |
Why?
|
| Translocation, Genetic | 4 | 2015 | 71 | 0.130 |
Why?
|
| Nuclear Matrix-Associated Proteins | 1 | 2015 | 14 | 0.110 |
Why?
|
| Aortic Coarctation | 1 | 2015 | 11 | 0.110 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2015 | 14 | 0.110 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2013 | 20 | 0.100 |
Why?
|
| Heart Valve Diseases | 1 | 2015 | 95 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2008 | 727 | 0.100 |
Why?
|
| Cytogenetics | 1 | 2013 | 9 | 0.100 |
Why?
|
| Prenatal Diagnosis | 1 | 2013 | 40 | 0.100 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2013 | 46 | 0.100 |
Why?
|
| Aortic Valve | 1 | 2015 | 190 | 0.100 |
Why?
|
| Interleukin-2 | 1 | 2013 | 167 | 0.100 |
Why?
|
| Genetic Testing | 1 | 2013 | 140 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 297 | 0.090 |
Why?
|
| src-Family Kinases | 1 | 2012 | 64 | 0.090 |
Why?
|
| Autistic Disorder | 3 | 2013 | 147 | 0.090 |
Why?
|
| Oligonucleotides | 1 | 2013 | 226 | 0.090 |
Why?
|
| Cataract | 1 | 2011 | 54 | 0.090 |
Why?
|
| RNA-Binding Proteins | 1 | 2015 | 443 | 0.090 |
Why?
|
| Cell Adhesion Molecules | 1 | 2011 | 92 | 0.090 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2012 | 204 | 0.090 |
Why?
|
| Neoplastic Stem Cells | 1 | 2012 | 199 | 0.080 |
Why?
|
| Humans | 16 | 2026 | 64278 | 0.080 |
Why?
|
| Chromosome Mapping | 2 | 2008 | 290 | 0.080 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2024 | 329 | 0.080 |
Why?
|
| Cell Line | 3 | 2011 | 2055 | 0.070 |
Why?
|
| Human Genome Project | 1 | 2008 | 4 | 0.070 |
Why?
|
| Genomics | 2 | 2026 | 379 | 0.070 |
Why?
|
| NFI Transcription Factors | 1 | 2007 | 7 | 0.070 |
Why?
|
| Haploidy | 1 | 2007 | 11 | 0.070 |
Why?
|
| Neuropeptides | 1 | 2008 | 81 | 0.070 |
Why?
|
| Urogenital Abnormalities | 1 | 2007 | 12 | 0.070 |
Why?
|
| Nervous System Malformations | 1 | 2007 | 13 | 0.070 |
Why?
|
| Calcium Channels | 1 | 2007 | 103 | 0.070 |
Why?
|
| Gingival Hyperplasia | 1 | 2007 | 3 | 0.070 |
Why?
|
| Hypertrichosis | 1 | 2007 | 4 | 0.070 |
Why?
|
| Glycoproteins | 1 | 2008 | 189 | 0.060 |
Why?
|
| Mice | 6 | 2015 | 11004 | 0.060 |
Why?
|
| Cytarabine | 1 | 2026 | 38 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 2 | 2008 | 416 | 0.060 |
Why?
|
| Acetylation | 1 | 2005 | 123 | 0.060 |
Why?
|
| Aged, 80 and over | 2 | 2026 | 5528 | 0.060 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2024 | 27 | 0.050 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2024 | 82 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 3 | 2013 | 167 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2003 | 12 | 0.050 |
Why?
|
| Syndrome | 3 | 2007 | 180 | 0.050 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2026 | 356 | 0.050 |
Why?
|
| Histones | 1 | 2005 | 486 | 0.050 |
Why?
|
| Epigenesis, Genetic | 1 | 2005 | 391 | 0.050 |
Why?
|
| Animals | 6 | 2015 | 20963 | 0.050 |
Why?
|
| Male | 6 | 2026 | 30321 | 0.050 |
Why?
|
| Repressor Proteins | 1 | 2024 | 348 | 0.050 |
Why?
|
| Blast Crisis | 1 | 2021 | 9 | 0.040 |
Why?
|
| Genes, p53 | 1 | 2021 | 51 | 0.040 |
Why?
|
| Adolescent | 2 | 2026 | 6305 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2026 | 909 | 0.040 |
Why?
|
| Disease Progression | 1 | 2024 | 1176 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2021 | 309 | 0.040 |
Why?
|
| Aged | 2 | 2026 | 14662 | 0.040 |
Why?
|
| CpG Islands | 2 | 2013 | 216 | 0.030 |
Why?
|
| Female | 4 | 2026 | 33380 | 0.030 |
Why?
|
| Adult | 2 | 2026 | 17133 | 0.030 |
Why?
|
| Middle Aged | 2 | 2026 | 17921 | 0.030 |
Why?
|
| Wnt-5a Protein | 2 | 2007 | 8 | 0.030 |
Why?
|
| Wnt Proteins | 2 | 2007 | 100 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2015 | 2019 | 0.030 |
Why?
|
| Young Adult | 1 | 2026 | 4781 | 0.030 |
Why?
|
| Mutagenesis, Insertional | 1 | 2015 | 89 | 0.030 |
Why?
|
| Genetics, Medical | 1 | 2013 | 11 | 0.030 |
Why?
|
| Metaphase | 1 | 2013 | 36 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2015 | 265 | 0.020 |
Why?
|
| Genes, abl | 1 | 2012 | 9 | 0.020 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2012 | 17 | 0.020 |
Why?
|
| PAX5 Transcription Factor | 1 | 2012 | 13 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2012 | 31 | 0.020 |
Why?
|
| K562 Cells | 1 | 2012 | 58 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2013 | 460 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2013 | 237 | 0.020 |
Why?
|
| Developmental Disabilities | 1 | 2013 | 116 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2015 | 405 | 0.020 |
Why?
|
| Nectins | 1 | 2011 | 3 | 0.020 |
Why?
|
| NIMA-Related Kinases | 1 | 2011 | 5 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2012 | 110 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 497 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2012 | 285 | 0.020 |
Why?
|
| Intellectual Disability | 1 | 2013 | 172 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2012 | 312 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2015 | 1375 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2011 | 203 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2013 | 1001 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2008 | 10 | 0.020 |
Why?
|
| Karyotyping | 1 | 2007 | 47 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2007 | 24 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2007 | 28 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2007 | 23 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 2007 | 41 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2007 | 197 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2012 | 2140 | 0.020 |
Why?
|
| Ureter | 1 | 2007 | 37 | 0.020 |
Why?
|
| Calcium Channels, L-Type | 1 | 2007 | 26 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2008 | 185 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2007 | 156 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2008 | 674 | 0.020 |
Why?
|
| Spinal Cord | 1 | 2007 | 206 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2007 | 205 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2007 | 404 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2012 | 3450 | 0.010 |
Why?
|
| Kidney | 1 | 2007 | 455 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2007 | 431 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2007 | 644 | 0.010 |
Why?
|
| Chromosome Fragile Sites | 1 | 2003 | 1 | 0.010 |
Why?
|
| Chromosome Fragility | 1 | 2003 | 2 | 0.010 |
Why?
|
| Genes, Overlapping | 1 | 2003 | 2 | 0.010 |
Why?
|
| Limb Deformities, Congenital | 1 | 2003 | 3 | 0.010 |
Why?
|
| Pseudogenes | 1 | 2003 | 12 | 0.010 |
Why?
|
| Williams Syndrome | 1 | 2003 | 4 | 0.010 |
Why?
|
| Expressed Sequence Tags | 1 | 2003 | 28 | 0.010 |
Why?
|
| Gene Duplication | 1 | 2003 | 33 | 0.010 |
Why?
|
| Euchromatin | 1 | 2003 | 16 | 0.010 |
Why?
|
| Phenotype | 1 | 2007 | 1222 | 0.010 |
Why?
|
| Retroelements | 1 | 2003 | 42 | 0.010 |
Why?
|
| Genomic Imprinting | 1 | 2003 | 49 | 0.010 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2003 | 38 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2003 | 165 | 0.010 |
Why?
|
| Databases, Genetic | 1 | 2003 | 90 | 0.010 |
Why?
|
| Infant | 1 | 2007 | 1664 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2012 | 3070 | 0.010 |
Why?
|
| Computational Biology | 1 | 2003 | 357 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 1997 | 0.010 |
Why?
|
| RNA | 1 | 2003 | 429 | 0.010 |
Why?
|
| Child | 1 | 2007 | 4583 | 0.010 |
Why?
|
| Neoplasms | 1 | 2003 | 1392 | 0.010 |
Why?
|